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The appropriate supply of dNTPs is critical for cell
growth and genome integrity. Here, we investigated
the interrelationship between dUTP pyrophospha-
tase (dUTPase) and ribonucleotide reductase (RNR)
in the regulation of genome stability. Our results
demonstrate that reducing the expression of
dUTPase increases genome stress in cancer. Anal-
ysis of clinical samples reveals a significant correla-
tion between the combination of low dUTPase and
high R2, a subunit of RNR, and a poor prognosis in
colorectal and breast cancer patients. Furthermore,
overexpression of R2 in non-tumorigenic cells
progressively increases genome stress, promoting
transformation. These cells display alterations in
replication fork progression, elevated genomic ura-
cil, and breaks at AT-rich common fragile sites.
Consistently, overexpression of dUTPase abolishes
R2-induced genome instability. Thus, the expression
level of dUTPase determines the role of high R2 in
driving genome instability in cancer cells.
INTRODUCTION
Genome instability in cancers is a driving force for tumor evolu-
tion that contributes to the development of distant metastasis or
resistance to anti-cancer treatments (Burrell et al., 2013b; Be-
dard et al., 2013). In the past three decades, signaling pathways
controlling checkpoints and DNA repair have been extensively
studied in cancer development (Kruiswijk et al., 2015; RoosCell R
This is an open access article undet al., 2016; Jeggo et al., 2016). Although the fidelity of the incor-
poration of four deoxynucleotide triphosphates (dNTPs) during
DNA replication and repair is the foundation of genome stability
(Mathews, 2015), our understanding of how dNTP supply gov-
erns genome instability in cancers is relatively limited. Replica-
tion stress is one important factor that causes genome instability
(Chan et al., 2009, Burrell et al., 2013a, Zeman and Cimprich,
2014, Minocherhomji et al., 2015). It has been shown that
dNTP deficiency can lead to replication stress, thereby promot-
ing transformation of non-tumorigenic cells (Bester et al., 2011).
However, in most cancer cells, dNTP synthesis enzymes are
often highly expressed. How the alteration in dNTP synthesis af-
fects genome instability via replication stress in cancer cells is
not clear.
Tumor cells demand dNTP synthesis for proliferation. Ribonu-
cleotide reductase (RNR), composed of RRM1 and RRM2 (also
known as R2)/RRM2B subunits, plays a central role in dNTP syn-
thesis (Nordlund and Reichard, 2006). The expression of the R2
subunit is stringently regulated by the cell-cycle control and DNA
damage signal (Chabes et al., 2003, 2004; D’Angiolella et al.,
2012). As such, the cellular functionality of RNR is correlated
with the level of R2. The role of R2 in cancer biology is well docu-
mented. R2 is on the list of the top 10% most highly expressed
genes in 73 of the 168 cancer tissues (Aye et al., 2015) and has
been reported as amarker of poor prognosis in colorectal cancer
(CRC) patients (Lu et al., 2012; Liu et al., 2013). Moreover, trans-
genic mice overexpressing R2 develop lung tumors and
generate a mutator phenotype (Xu et al., 2008). A number of
studies in yeast have reported that gain-of-function mutation of
RNR increases dNTP levels to promote cell survival after DNA
damage but with compromised fidelity, therefore increasing mu-
tation frequency (Chabes et al., 2003; Lis et al., 2008; Sabouri
et al., 2008; Davidson et al., 2012). Replication stress and theeports 16, 1287–1299, August 2, 2016 ª 2016 The Author(s). 1287
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increased incidence of misincorporation by replicative polymer-
ases and error-prone polymerases have been shown to be
responsible for RNR-induced mutagenesis (Sabouri et al.,
2008; Davidson et al., 2012). To date, direct evidence of high
R2 in driving replication stress in cancer cells has been lacking.
Also unclear is whether other enzyme(s) in nucleotide synthesis
can have an effect on R2-regulated genome instability.
Our laboratory has shown previously that blocking thymidylate
kinase causes deoxyuridine triphosphate (dUTP)-mediated toxic
DNA repair in tumor cells because of high R2 expression (Hu
et al., 2012). This prompted us to understand how dUTP forma-
tion is regulated in cancer cells and whether replication stress in
cancer cells involves dUTP incorporation. Given the inability of
DNA polymerases in distinguishing between dUTP and deoxy-
thymidine triphosphate (dTTP) in eukaryotic cells, the cellular
dUTP/dTTP ratio is normally kept within 0.1% to 3% (Zhang
et al., 2011). One of four RNR-catalyzed reactions generates de-
oxyuridine diphosphate (dUDP), which is phosphorylated by
nucleoside diphosphate (NDP) kinase (NDK) to form dUTP. Thy-
midylate synthase (TS) catalyzes the conversion of deoxyuridine
monophosphate (dUMP) to deoxythymidine monophosphate
(dTMP). Cellular dUMP can be derived either from the hydrolysis
of dUTP by dUTP pyrophosphatase (dUTPase), deamination
of deoxycytidine monophosphate (dCMP) by deoxycytidylate
deaminase (DCTD), or phosphorylation of deoxyuridine (dU)
from deamination of deoxycytidine by cytidine deaminase
(CDA). Therefore, dUTPase has a dual function in dTTP formation
and dUTP sanitization. In this study, we found that the expressed
level of dUTPase is not necessarily correlated with R2 in cancer
cells but that it determines R2-induced genome instability in can-
cer cells.
RESULTS
The Inverse Correlation between the Level of dUTPase
with the Extent of Genome Stress in Cancer Cells
Wechose four cancer cell lines,MDA-MB231,MCF7, LOVO, and
HT29, to compare their basal levels of genome stress by
measuring 53BP1 foci, which have been shown to indicate
genome lesions (Lukas et al., 2011). MDA-MB231 and MCF7
are breast cancer cells, and LOVO and HT29 are colorectal can-
cer cells. We found that the amounts of 53BP1 foci were much
higher in MDA-MB231 and LOVO cells compared with MCF7
and HT29 cells (Figure 1A). Phosphorylation of ataxia telangiec-
tasia mutated (ATM) kinase (ATM) at Ser1981 (pATM) is another
DNA damagemark (Bakkenist and Kastan, 2003). The number of
pATM foci and the expression level of pATM were also higher in
these two cell lines (Figures 1B and S1A). In LOVO cells, pATM
foci were relatively low compared with those of 53BP1, and the
high frequency of 53BP1 foci in MDA-MB231 and LOVO cells
was associated with high levels of total 53BP1 in these cell lines.
The western blot analysis of dNTP synthesis enzymes showed
that MDA-MB231 and LOVO cells shared a common feature in
having very low expression of dUTPase protein (Figure 1C).
These four cancer cell lines expressed high levels of R2
compared with MCF-10a, a non-tumorigenic human mammary
epithelial cell line (Figure 1C). Figure 1D depicts the relationship
of these enzymes in dNTP synthesis. The clustering analysis of1288 Cell Reports 16, 1287–1299, August 2, 2016microarray data from 353 cell lines showed that the mRNA level
of R2 is most closely correlated with TS and dihydrofolate reduc-
tase (DHFR) but not dUTPase or CDA (Figure S2).
Despite high levels of CDA and TS in MDA-MB231 cells,
overexpression of dUTPase was sufficient to decrease 53BP1
and pATM foci in a catalysis-dependent manner (Figures 1E
and S1B). In LOVO cells, dUTPase overexpression also
reduced 53BP1 foci (Figure 1E). In MCF7 and HT29 cells con-
taining high levels of dUTPase, knockdown of dUTPase by
small hairpin RNA (shRNA) significantly increased the incidence
of high 53BP1 foci (Figure 2A). The number of pATM foci in
MCF7 cells was also increased by dUTPase knockdown (Fig-
ure S3). Re-introduction of an shRNA-resistant GFP-dUTPase
expression vector into MCF7 and HT29 cells depleted of
dUTPase revealed that expression of the wild-type (WT), but
not a catalytically dead (KD) mutant of dUTPase, was able to
decrease 53BP1 foci in these cells (Figure 2A). This indicates
that the catalytic function of dUTPase in dUTP hydrolysis
plays an important role in reducing genome lesions in cancer
cells. It has been reported that replication stress causes chro-
mosomal instability during mitosis (Chan et al., 2009; Burrell
et al., 2013a). Knockdown of dUTPase by shRNA in mitotic
MCF7 and HT29 cells also significantly increased the inci-
dences of lagging chromosomes and anaphase bridges (Fig-
ure 2B). Overall, these data imply that decreasing the
expression of dUTPase is sufficient to induce genome insta-
bility in these cancer cells.
The effect of dUTPase knockdown on four dNTP pools was
more significant in MCF7 than in HT29 cells (Figure 2C).
Because DNA polymerases cannot distinguish between dUTP
and dTTP, we treated cell extracts with glutathione S-trans-
ferase (GST)-dUTPase to eliminate dUTP prior to the in vitro
DNA polymerization reaction for dTTP pool determination. The
quantitation by this treatment was validated by spiking dUTP
in the assay (Figure S4). The incorporation values in the pres-
ence and absence of GST-dUTPase treatment showed that
dUTPase knockdown moderately increased the steady-state
pool of dUTP in MCF7 cells (Figure 2D). However, the effect of
dUTPase knockdown on the dTTP/dUTP pool was small in
HT29 cells (Figure 2D).
The Combination of Low dUTPase and High R2 in
Tumors Correlates with Poor Survival of Cancer
Patients
It is known that genome instability increases tumor heterogene-
ity, which drives cancer progression (Marusyk and Polyak, 2010;
Burrell et al., 2013b; Bedard et al., 2013). We then investigated
whether the level of dUTPase as a factor affects cancer
progression in patients. Immunohistochemistry (IHC) staining
of dUTPase in surgical tumors from 209 CRC patients showed
differences in cytoplasmic and nuclear distribution, in which
score 0/1 was designated as low and 2/3 as high (Figure 3A).
By score evaluation, Kaplan-Meier analysis demonstrated that
patients with tumors expressing low dUTPase in nuclei had
slightly poorer overall survival than those with high dUTPase in
nuclei (Figure 3B). There was no significant correlation in overall
survival between low and high dUTPase in the cytoplasm (Fig-
ure 3B). The pathological analysis of these CRC patients in the
Figure 1. A Low Expression Level of dUTPase Contributes to High Genome Stress in Colorectal and Breast Cancer Cells
(A and B) Analysis of genome stress in breast cancer cells (MDA-MB231 and MCF7) and colorectal cancer cells (LOVO and HT29). These cells were fixed for IF
staining of (A) 53BP1 or (B) pATM. Cells containing five or more 53BP1 foci and two or more pATM foci were counted and expressed as a percentage. For each
experiment,R300 cells were counted for each cell line. All error bars represent SEM (n = 3). Scale bars, 10 mm.
(C) Levels of nucleotide synthesis enzymes in MDA-MB231, LOVO, MCF7, HT29, and MCF-10a cells by western blot analysis.
(D) The pathway scheme for four dNTP synthesis. NDPase, NDP phosphatase; TMPK, thymidylate kinase; TK, thymidine kinase.
(E) The catalytic function of dUTPase in determining genome stress. MDA-MB231 and LOVO cells were transfected with GFP vector, GFP-dUTPaseWT, or GFP-
dUTPase KD for 2 days. Cells were fixed and stained with 53BP1 antibody. Representative images are shown at the left, and the outlines indicate the
nuclear boundaries of GFP-positive cells. The percentages of GFP-positive cells with five or more 53BP1 foci are shown at the right. 300 cells were analyzed
(n = 3). ***p < 0.001. Scale bars, 10 mm.categories of high and low nuclear/cytoplasmic dUTPase is
shown in Table 1. Because these tumor samples had been
used previously for IHC analysis of R2 (Liu et al., 2011, 2013),
we further incorporated IHC data of nuclear dUTPase into high
and low R2 groups as described previously. The analysisdemonstrated that progression-free survival in the combined
group of low nuclear dUTPase/high R2 in tumors was signifi-
cantly poorer than that of high nuclear dUTPase/high R2 (Fig-
ure 3C). Contrarily, in the low R2 group, the level of nuclear
dUTPase made no significant difference in survival (Figure 3C).Cell Reports 16, 1287–1299, August 2, 2016 1289
Figure 2. The Catalytic Function of dUTPase Is
Required for Reducing Genome Stress in Cancer
Cells
(A and B) Effect of dUTPase knockdown and functional
rescue on genome instability. MCF7 and HT29 cells
were infected with a lentivirus of dUTPase shRNA, fol-
lowed by puromycin selection.
(A) MCF7 cells with dUTPase knockdown by lentivirus
infection were transfected with GFP vector, GFP-
dUTPase WT, or GFP-dUTPase KD for 2 days. Cells
were fixed and stained with 53BP1 antibody with
Hoechst. Left: representative images. Outlines indicate
the nuclear boundaries of GFP-positive cells. Right: the
percentages of GFP-positive cells with five or more
53BP1 foci per cell. Error bars show SE. 300 cells
were counted under each condition (n = 3). *p < 0.05,
**p < 0.01, ***p < 0.001. Scale bars, 10 mm.
(B) Cells were mitotically synchronized by overnight
treatment with nocodazole and released for 1 hr, fol-
lowed by fixation for IF staining of H3-Ser10p as a
mitotic marker with Hoechst. Left: representative im-
ages of metaphase lagging and anaphase bridge. The
percentages of mitotic cells with a lagging chromosome
or bridge are shown as mean ± SEM. 72–164 HT29
cells and 304–821 MCF7 cells were analyzed (n = 3).
*p < 0.05, **p < 0.01.
(C) The effect of dUTPase knockdown on dNTP pools.
MCF7 and HT29 cells with and without dUTPase
knockdown were harvested for analysis of dNTP
pools. Results are expressed as mean ±SE. *p < 0.05,
**p < 0.01.
(D) The levels of dTTP determined in the presence
and absence of GST-dUTPase in MCF7 and HT29 cells.
*p < 0.05.
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Figure 3. Low dUTPase and High R2 in Tumors Correlate with a Poor Prognosis for Colorectal Cancer Patients
The effect of dUTPase/R2 interaction on survival of CRC patients is illustrated.
(A) Cytosolic (CY) and nuclear (NU) staining of dUTPase in CRC samples. Scores were organized by a rating scale as follows: negative (0), weakly positive (1),
positive (2) and strongly positive (3). To enhance the power of the study, all participants were restratified as having low (scores 0 and 1) and high (scores 2 and 3)
dUTPase for the next analysis.
(B) Kaplan-Meier analysis indicating that nuclear dUTPase is correlated with the overall survival of CRC patients.
(C) Kaplan-Meier analysis indicating that low nuclear dUTPase and high R2 are correlated with poor overall survival of 209 CRC patients. The tick marks on the
Kaplan-Meier curves represent censored subjects. The number of patients at risk is listed below the survival curves.We also analyzed microarray data of tumors from breast cancer
patients in the GEO database. The results showed that the group
of low dUTPase/high R2 correlated with poorer disease-freesurvival in 1,592 breast cancer patients (Figure S5). Thus, the
combination of low dUTPase and high R2 predicts a poor prog-
nosis in colorectal and breast cancer.Cell Reports 16, 1287–1299, August 2, 2016 1291
Table 1. Pathoclinical Features of Colorectal Cancer Patients and Immunohistochemistry Score of dUTPase
Cases
Cytoplasmic dUTPase Nuclear dUTPase
Higha Lowa p Value Higha Lowa p Value
Distant Metastasis
No 169 62 107 0.124 98 71 0.004*
Yes 40 20 20 13 27
Age
<40 7 2 5 0.642 1 6 0.291
40–49 14 3 11 7 7
50–59 48 19 29 27 21
60–69 61 24 37 33 28
70–79 59 24 35 30 29
R80 20 3 17 13 7
Gender
Male 102 40 62 0.996 53 49 0.745
Female 107 42 65 58 49
Differentiation
Well 20 7 13 0.825 10 10 0.562
Mod 166 65 101 85 81
Poor 19 9 10 13 6
Tumor Invasion
Within serosa 23 11 12 0.425 11 12 0.636
Adjacent organ 179 70 109 95 84
Tumor Location
Rectum 49 14 35 0.076 30 19 0.191
Colon 160 68 92 81 79
Lymph Node
Not involved 157 61 96 87 70
Involved 52 21 31 0.845 24 28 0.247
aHigh includes immunohistochemistry scores 2 and 3; low is scores 0 and 1.
*p < 0.01.R2 Overexpression Progressively Increases Genome
Instability to Cause Cellular Transformation
The level of R2 is high in most cancer cells and low in non-tumor-
igenic cells (Aye et al., 2015). We found that non-tumorigenic
MCF-10a cells expressed very low levels of R2 but that the level
of dUTPasewas compatible with those inMCF-7 andHT29 cells,
as shown in Figure 1C. We then used MCF-10a cells to establish
cells stably expressing high R2 (Figure 4A). It has been discussed
in a report that, unlike in yeast, constitutive expression of R2 un-
der SV40 promoter control is lethal to normal mammalian cells
(Chabes and Stillman, 2007). However, we found that control
and R2 MCF10a cells had similar growth rates (Figure S6A).
The steady-state levels of dTTP, deoxy ATP (dATP), deoxycyti-
dine triphosphate (dCTP), and deoxyguanosine triphosphate
(dGTP) were higher in R2 than in control cells by 4.9-, 10.5-,
5.3-, and 3.2-fold, respectively (Figure 4B). As mentioned,
dTTP determination was performed in extract pretreated with
GST-dUTPase to exclude the reading from dUTP. Of note, the
A/T ratio was increased 2-fold. RNR catalyzes reactions that
generate deoxyadenosine diphosphate (dADP), deoxyguano-
sine diphosphate (dGDP), deoxycytidine diphosphate (dCDP),
and dUDP, which are subsequently converted to corresponding1292 Cell Reports 16, 1287–1299, August 2, 2016dNTPs, including dUTP. By treating the cell extracts with and
without GST-dUTPase, we were able to quantify the steady-
state pool of dUTP. Although the level of dUTPwas undetectable
in control cells, R2 overexpression elevated dUTP to a detect-
able level in a wide range of variations (Figure 4C). To know the
association of R2 expression with genome stress, we analyzed
the amount of 53BP1 foci and found a significant increase with
passage number (Figure 4D). This indicates the progressive
accumulation of genome lesions through cell proliferation. Anal-
ysis of pATM foci gave similar results (Figure S6B). Protein levels
of R2 and other enzymes for dNTP biosynthesis were similar in
low- and high-passage cells (Figure S6C). Furthermore, a small
proportion of R2 cells at high but not low passage developed
anchorage-independent growth (Figure 4E). Likely, R2 overex-
pression progressively increased genome instability through a
series of cell passaging, leading to cellular transformation in a
small sub-population of cells.
Alteration of Replication Fork Progression by R2
Overexpression
The major function of RNR is to provide dNTPs for DNA replica-
tion. Next we performed a DNA fiber assay to directly assess the
Figure 4. R2 Overexpression Promotes
Passage-Dependent Genome Stress in
MCF-10a Cells
(A–E) Effects of enforcing R2 overexpression in
non-tumorigenic cells on dNTP pools, trans-
formation, and genome stress. MCF-10a cells
were infected with a lentivirus with mCherry empty
vector (EV) and mCherry-R2 (R2). Cells were
subcultured at 1:8 dilution ratio to confluence for
each passage.
(A–C) Cells at passage 2 were harvested for (A)
western blot analysis, (B) four dNTPs, and (C)
dUTP measurement. ND, non-detectable. Error
bars shows SE (n = 6). **p < 0.01.
(D) Cells at the indicated passage were fixed for IF
staining of 53BP1 with Hoechst. Scale bar, 10 mm.
975–1,776 cells were counted (n = 3). *p < 0.05,
**p < 0.01.
(E) Cells were seeded for a soft agar assay. Col-
onies of >50 mmwere counted (n = 3). ***p < 0.001.effect of R2 elevation on DNA replication. DNA fiber analysis
showed that R2 overexpression increased the replication fork
rate (Figure 5A). This is consistent with what has been reported
in yeast strains: that high dNTP pools facilitate replication fork
progression (Poli et al., 2012). We further tested DNA replication
in these cells after replication stress induction. Cells were pulse-
labeled with chlorodeoxyuridine (CldU) and then treated with
aphidicolin to stall replication. After aphidicolin washout, the
restart of the replication fork was assayed by iododeoxyuridine
(IdU) chase labeling. Compared with control cells, R2 cells dis-
played a significant reduction in IdU-labeled DNA fiber linking
to CldU pre-labeled DNA fiber, indicating that R2 overexpression
markedly suppressed the restart of processive replication (Fig-
ure 5B). Probably, after recovery from fork stalling, collapse of
replication forks occurs in R2 cells, prohibiting the restart of
fork progression. By analysis of the chromatin fraction, we found
that the level of aphidicolin-induced pATM associated with chro-
matin was significantly higher in R2 cells (Figure 5C). The amount
of chromatin-associated pATM was diminished after releaseCell Refrom aphidicolin arrest. It is known that
DNA replication can be switched to trans-
lesion replication when encountering a
damaged template (Friedberg et al.,
2005; Prakash et al., 2005; Waters et al.,
2009). Monoubiquitinated proliferating
cell nuclear antigen (PCNA; Ub-PCNA) is
a mark of error-prone translesion synthe-
sis (Chang and Cimprich, 2009; Chen
et al., 2011). We found a higher amount
of Ub-PCNA induced by aphidicolin treat-
ment in R2 cells than in control cells
(Figure 5C).
Because there was a skewed increase
in dATP in R2 cells, we then incubated
these R2 cells with growth medium sup-
plemented with 10 mM thymidine (dT) for
7–15 days and performed an analysis ofreplication fork restart after withdrawal from aphidicolin treat-
ment. Presumably, the uptake of thymidine leads to increased
dTTP formation via the salvage pathway in these cells. The re-
sults revealed that long-term thymidine supplementation in
growth medium drastically decreased the number of non-re-
starting forks in R2 cells (Figure 5D). It should be emphasized
that this long-term thymidine treatment in growth medium did
not slow down the replication fork rate in R2 cells (Figure S7).
The thymidine supplement also reduced 53BP1 foci and aberra-
tions in anaphase chromatin bridges in these R2 cells (Figures 5E
and 5F). Thus, additional input of dTTP is sufficient to overcome
R2-induced changes in replication stress and genome instability.
R2 Overexpression Increases Uracil in the Genome and
Breaks at AT-Rich Common Fragile Sites and
dUTP-Dependent 53BP Focus Formation
The reversal effect of thymidine supplementation led us to
assess the involvement of uracil misincorporation by R2 overex-
pression. To test this speculation, we measured genomic uracilports 16, 1287–1299, August 2, 2016 1293
Figure 5. The Reversal Effect of Thymidine
Supplement on R2-Induced Alteration in
Replication Stress andGenomeAberrations
(A–C) Replication stress in control and R2 cells.
(A) DNA fiber analysis is exemplified at the left
(scale bar, 10 mm). Control and R2 MCF-10a
cells at passage 8 were incubated sequentially
with CldU (red) and IdU (green) for 30 min. Repli-
cation rates at individual replication forks were
measured. Replication fork velocity (IdU) is shown
as mean replication fork rate ± SE. 54–87 fibers
were counted under each condition (n = 3).
***p < 0.001.
(B) Control and R2 cells at passage 8 were incu-
bated with CldU (red label), after which cells were
washed and refreshed with medium containing
aphidicolin (APH) for 9 hr. To restart replication,
cells were washed and refed with medium con-
taining IdU (green label). Restarted forks are indi-
cated by the consecutive red- and green-labeled
fibers, and fibers with red labeling alone indicate
non-restarted forks, as exemplified at the left
(scale bar, 10 mm). 2,088–2,267 fibers were
counted under each condition (n = 3). **p < 0.01.
(C) Control and R2 cells at passage 2 were treated
with APH for 16 hr, after which aphidicolin was
washed out for release. Cells were harvested at
the indicated time for chromatin fractionation. The
chromatin-bound proteins were analyzed by
western blot using antibodies of pATM, ATM, Ub-
PCNA, PCNA, and lamin B as a loading control.
(D–F) The effect of thymidine supplementation on
R2-induced replication stress. R2 cells at passage
3 were incubated in cultured medium in the pres-
ence or absence of 10 mM thymidine for 15 days
and then subjected to a DNA replication restart
assay and IF staining of 53BP1.
(D) The percentages of non-restarted forks. 2,088–
2,476 fibers were counted under each condition
(n = 3). **p < 0.01.
(E) The percentages of cells containing five or
more 53BP1 foci per cell. Left: representative im-
ages (scale bar, 10 mm). 491–709 cells were
analyzed in each experiment (n = 3). **p < 0.01.
(F) Cells were synchronized by overnight treatment
with nocodazole, released for 1 hr, and then fixed
for IF staining of H3-Ser10p as a mitotic marker
with Hoechst. The percentages of cells with
anaphase bridges are shown. 600 cells were
counted in each experiment (n = 3). ***p < 0.001.in control and R2 cells by mass spectrometry analysis. The re-
sults showed that the amount of genomic uracil was increased
in R2 cells but not in R2/dUTPase cells (Figure 6A). It has been1294 Cell Reports 16, 1287–1299, August 2, 2016shown that 53BP1 protects genome le-
sions and unreplicated regions such as
common fragile sites (CFSs) (Lukas
et al., 2011). We then analyzed all dou-
ble-stranded breaks in CFSs in these
cells (Figure 6B). The ‘‘all break’’ method
includes primer extension, linker ligation,
nested PCR, and direct sequencing of
PCR products. It detects breaks on sin-gle-stranded DNA, and these breaks can be derived from sin-
gle-stranded nicks and double-stranded breaks with blunt or
staggered ends. The double-stranded breaks were measured
Figure 6. R2 Overexpression Increases
Uracil in the Genome Breaks at AT-Rich
Common Fragile Sites and dUTP-Depen-
dent Chromosome Instability
(A) Analysis of genomic uracil. The amount of uracil
in the genomic DNA of MCF-10a cells was
analyzed, as depicted at the left. Extracted
genomic DNA was incubated with UNG, which
cleaves uracil from DNA. After filtration and solid
phase extraction, purified uracil and isotope-
labeled uracil were analyzed with LC-MS/MS for
quantitation. The amounts of genomic uracil in
MCF-10a cells overexpressing mCherry EV,
mCherry-R2 (R2), or mCherry-R2 and GFP-
dUTPase at passage 6 are shown at the right. Data
are the average from two independent experi-
ments.
(B) Expression of CFSs in control and R2 cells.
MCF-10a cells at passage 4 were harvested for
genomic DNA isolation, followed by ligation-
mediated PCR to analyze DNA breaks at the
indicated regions. Both FHIT and WWOX are AT-
rich fragile sites located within FRA3B and
FRA16B, respectively. RET is a GC-rich fragile
site. Non-fragile site regions are 12p12 and G6PD
(nR 3). **p < 0.01.
(C) The binding of 53BP1 to CFS. Cells at passage
4 were subjected to 53BP1ChIP analysis followed
by qPCR for FRA3B, 12p12, RET, and G6PD
(n = 3). **p < 0.01.
(D–F) The effect of dUTPase overexpression on
R2-induced genome instability. Control and R2
cells were infected with a lentivirus of GFP vector,
GFP-dUTPase WT, and GFP-dUTPase KD. These
cells were subjected to (D) western blot analysis
and (E) IF staining of 53BP1 foci. Outlines indicate
the nuclear boundaries of GFP-positive cells.
Scale bar, 10 mm. Right: percentages of GFP-
positive cells with more than ten 53BP1 foci. 150
cells were counted in each experiment (n = 3).
*p < 0.05.
(F) Cells were treated with nocodazole overnight
and released for 1 hr. Cells were fixed for DNA
staining by Hoechst. Percentages of GFP-positive
cells with anaphase bridges are shown. 125 cells
were counted in each experiment (n = 3). *p < 0.05.by using genomic DNA directly ligated to duplex linkers, followed
by nested PCR. Therefore, it only detects blunt-ended double-
stranded breaks. Analysis of DNA breaks in several fragile sites
indicated that R2 cells at the middle passage had a higher fre-
quency of all breaks at AT-rich CFSs, including FRA3B and
FRA16D, but not at RET, a GC-rich CFS, or non-fragile site re-
gions, such as 12p12 andG6PD (Figure 6B). Chromatin immuno-
precipitation (ChIP) analysis showed that 53BP1 binding toCell ReFRA3B, an AT-rich CFS, was markedly
higher in R2 than in control cells, whereas
there was no significant difference at
RET, 12p12, and G6PD (Figure 6C).
Thus, R2 overexpression renders more
breaks at FRA3B, which are bound by
53BP1.We conclude that there is a corre-lation of R2-induced genome instability with uracil incorporation
and more breaks in some AT-rich CFS.
We further investigated the causative role of dUTP formation in
R2-induced 53BP1 foci. R2 cells were further infected with lenti-
viral vector expressing the wild-type or a catalytically dead
mutant of GFP-dUTPase (Figure 6D). Co-expression of the
wild-type, but not a catalytically dead mutant, of dUTPase abol-
ished R2-induced 53BP1 foci and aberrations in anaphaseports 16, 1287–1299, August 2, 2016 1295
chromatin bridges (Figures 6E and 6F). Together, these data
suggest that R2 overexpression increases replication stress
dependent on dUTP because dUTP misincorporation in DNA is
targeted and excised by base excision repair to generate DNA
breaks (Krokan and Bjøra˚s, 2013).
DISCUSSION
In this study, we investigated the role of dUTPase in genome
instability developed in cancer cells. Our data revealed that a
low expression level of dUTPase is sufficient to increase
53BP1 and pATM foci in cancer cells that constantly express
a high level of R2. Our data suggest a model in which high
RNR in cancer cells interplays with the sanitizing control of
dUTP by dUTPase to influence the load of dUTP-mediated repli-
cation stress, probably because of DNA damage driven by the
removal of uracil via base excision repair (Krokan and Bjøra˚s,
2013). In cancer development, it is known that what kills patients
is the clonal evolution of tumors driven by genome instability,
leading to heterogeneity, drug resistance, and metastasis of
the tumors. In agreement, we found that the combination of
low dUTPase/high R2 in tumors correlates with a poor prog-
nosis in colorectal cancer and breast cancer. These data sug-
gest the involvement of dUTPase and R2 levels in predicting
tumor progression, which is important for therapeutic deci-
sion-making.
There are two isoforms of dUTPase in cells, one in mitochon-
dria and the other in the nucleus, responsible for hydrolysis of
dUTP. The expression of mitochondrial dUTPase is constitutive,
whereas the nuclear form is cell cycle-regulated, peaking at
S phase, and is downregulated by DNA damage-induced p53
(Wilson et al., 2009). A low level of dUTPase in LOVO and
MDA-MB231 cells is unlikely because of the lack of S phase pop-
ulation or the presence of p53 because both cell lines are defi-
cient in functional p53. Therefore, the mechanism by which the
expression of dUTPase is suppressed in these cells remains to
be investigated. It has been reported that the increased expres-
sion of dUTPase in cancer cells is a critical factor in resistance to
TS inhibitors, including 5-fluorouracil (5-FU) and fluorodeoxyuri-
dine (FUdR) (Canman et al., 1993; Ladner et al., 2000; Wilson
et al., 2014). In this study, we found that the elevation of dUTPase
is sufficient to antagonize R2-induced genome stress observed
in cancer and pre-cancerous cells. Because dUTPase inhibition
has potential in clinical applications for anti-cancer treatment,
our results brings attention to its possible complication in sec-
ondary cancer formation.
In this study, we found that the levels of R2, CDA, and TS
were relatively high in MDA-MB231 cells. Presumably, the
TS-catalyzed reaction is able to channel dUMP to dTMP. There-
fore, the question is why genome stress in these cells is sup-
pressed by overexpression of dUTPase. Similarly, genome
stress induced by R2 overexpression in MCF-10a cells is also
overcome by dUTPase overexpression. Moreover, the steady-
state level of dUTP was still far below that of dTTP in these cells.
Two possibilities are proposed for these observations. In cells
deficient of dUTPase, dTTP level might be depleted at late
S phase, resulting in increased incidence of dUTP incorporation
in the late replication regions. Relevant to this hypothesis, uracil1296 Cell Reports 16, 1287–1299, August 2, 2016sequencing data in yeast have indicated a higher incidence of
uracil incorporation in the late replication regions (Bryan et al.,
2014). In this study, we found a higher level of breaks in AT-
rich fragile sites, FRA3B and FRA16D, which have been shown
to be replicated in late S phase (Durkin and Glover, 2007). The
mechanisms that lead to breaks in these CFSs have been pro-
posed because of the naturally occurring replication-perturbing
DNA structures (Durkin and Glover, 2007) and are promoted by
structure-specific endonucleases such as MUS81-EME1 or
ERCC1 in mitosis (Ying et al., 2013; Naim et al., 2013). In the
future, it will be interesting to determine whether the increased
expression of these CFSs in R2 cells is due to uracil incorpora-
tion in these sites.
Another possibility is that local concentration of dUTP/dTTP
during DNA replication might contribute to this phenomenon.
In a yeast study, it has been shown that active transcription re-
gions have elevated dUTP incorporation, implying that UTP for
transcription is converted to dUTP for DNA replication (Kim
and Jinks-Robertson, 2009). If so, RNR probably participates
in this local conversion. RNR is known as a cytosolic enzyme.
It has been shown that RNR is recruited to DNA damage sites
(Hu et al., 2012; Niida et al., 2010). After blocking nuclear export,
RNR was detected in the nuclei of cancer cells (D’Angiolella
et al., 2012). In immunohistochemistry analyses of tumors, nu-
clear R2 was also detectable. It is possible that RNR is dynami-
cally trafficked to the nuclear compartment during replication
and repair. Of note, the constant presence of dUTPase in the nu-
cleus explains its function in excluding dUTP misincorporation.
When cancer cells express a high level of R2 without a compat-
ible level of dUTPase, the chance of dUTP misincorporation into
DNA becomes high.
In summary, our results suggest that elevation of R2 without
coupling of dUTPase leads to dUTP-mediated genome insta-
bility. Because genome instability is a force driving tumor evolu-
tion toward heterogeneity, our study provides the molecular
foundation explaining poorer survival of CRC patients with tumor
context of high R2/low dUTPase. A future trial for cancer treat-
ment can be biomarker driven. Because the group of high R2/
low dUTPase had poorer survival, a new trial can be based on
the classification of these biomarkers.
EXPERIMENTAL PROCEDURES
Cell Culture and Establishment of Stable Cell Lines
MDA-MB231, LOVO, MCF-7, and HT29 cells were obtained from the ATCC.
MCF-10a cells were a kind gift from Dr. Wen-Hwa Lee (Department of Biolog-
ical Chemistry, University of California). MCF-10a cells stably expressing
mCherry, mCherry-R2, GFP vector, GFP-dUTPase WT, or GFP-dUTPase KD
were obtained by lentiviral infection with selection by incubation in medium
containing 1 mg/ml puromycin for mCherry expression or 1 mg/ml blasticidin
for GFP expression. Lentivirus packaging and infection were performed as
described previously (Hu et al., 2012).
Immunofluorescence Staining
Cells on glass coverslips were fixedwith 4%paraformaldehyde for immunoflu-
orescence (IF) staining as described previously (Hu et al., 2012). 53BP1 anti-
body was purchased from Santa Cruz Biotechnology (sc-22760, 1:800) and
phospho-histoneH3antibody fromMillipore (06-570, 1:800). Anti-pATM (phos-
pho-Ser1981) antibody was purchased from GeneTex (gtx61739, 1:1,000). All
IF images were observed using a Carl Zeiss fluorescence microscope
equipped with an AxioCam digital camera and analyzed by Axio Vision Rel.4.8
imaging software (Carl Zeiss).
Chromatin Fractionation and Western Blot Analysis
Chromatin fractionation was performed as described previously (Me´ndez and
Stillman, 2000). Briefly, nucleus pellets obtained from cells treated with hypo-
tonic solution were washed twice with solution B (3 mM EDTA, 0.2 mM EGTA,
1 mM DTT, 13 protease inhibitor cocktail 3 [539134, Millipore], 13 phospha-
tase inhibitor [P0044, Sigma-Aldrich], and 25 mM N-ethylmaleimide [E3876,
Sigma]), followed by centrifugation at 1,700 3 g for isolation of the insoluble
chromatin fractions. The chromatin fractions were sonicated for 5 min using
a Bioruptor UCD-200 ultrasonicator (Diagenode) to fragment DNA prior to
western blot analysis.
After addition of Laemmli solution to samples, proteins were separated by
SDS-PAGE (8%–11% [w/v] gel) and then transferred to polyvinylidene fluoride
membranes. After blocking by 5% non-fat milk, the blots were incubated with
the indicated primary antibody overnight at 4C: R2 (Santa Cruz, sc-10844), R1
(Santa Cruz, sc-11733), RRM2B (Santa Cruz, sc-10840), CDA (LifeSpan
BioSciences, LS-B1823), TS (ZYMED, 180399, now Thermo Fisher Scientific),
b-actin (Sigma-Aldrich, A5441), ATM (Cell Signaling, #2873), mono-ubiquityl-
PCNA (Lys164) (Cell Signaling Technology, 13439), PCNA (Santa Cruz, sc-
56), lamin B (Santa Cruz, sc-6216), glyceraldehyde 3-phosphate dehydroge-
nase (GAPDH; GeneTex, clone 6C5, gtx28245), and b-tubulin (Sigma-Aldrich,
T4026). Antiserum against human dUTPase and antibodies against human
TMPK and TK1 were produced as described previously (Chang et al., 1994;
Hu et al., 2012). The membranes were then treated with horseradish peroxi-
dase-conjugated secondary antibodies (Santa Cruz) for 1 hr, followed by
ECL detection according to the manufacturer’s instructions (Millipore).
ChIP and qPCR
Cells were crosslinked with 1% formaldehyde, and ChIP was performed as
described previously (Hu et al., 2012). Precipitated DNA was rehydrated and
analyzed by quantitative real-time PCR using the ABI StepOne system
(Applied Biosystems) with Fast SYBR Green PCR Master Mix (Kapa Bio-
systems). Primers for FRA3B, 12p12, RET, and G6PD are listed in Table S1.
Measurement of dNTP and dUTP Pools
Cells (106) were extracted with 1 ml of ice-cold 60% methanol at 20C, fol-
lowed by centrifugation at 16,000 3 g for 30 min. The supernatant was heat-
inactivated, vacuum-dried, and then rehydrated in 80 ml of water for cellular
dNTP measurement according to a method described previously (Ferraro
et al., 2010). For determining the levels of dUTP, rehydrated residuals were
incubated in the presence and absence of purified GST-dUTPase (30 ng) for
15 min at 37C and then subjected to dTTP measurement. The reduction in
DNA polymerase-mediated dNTP incorporation by GST-dUTPase incubation
was calculated to indicate the amount of dUTP.
Anchorage-Independent Cell Growth Assay
Cells (4 3 105) were suspended and overlaid in 0.35% agarose gel in a 6-well
plate. After 14 days of culture, colonies were fixed with crystal violet solution.
Colonies larger than 50 mm were counted per well.
DNA Fiber Assay
The DNA fiber assay was performed as described previously (Jackson and
Pombo, 1998). Briefly, cells seeding overnight were sequentially treated with
medium containing 25 mM of CldU (Sigma-Aldrich, C6891) and then 250 mM
of IdU (Sigma-Aldrich, I7125) for 30 min. For the fork restarting assay, cells
were treated with 6 mM of aphidicolin for 9 hr before IdU treatment. Cells, after
being washed and frozen at 80C, were spread on coverslip in spread solu-
tion (200 mM Tris-HCl, 50 mM EDTA, and 0.5% SDS) and air-dried. After fixa-
tion with methanol/acetic acid (3:1), denaturation, and blocking, DNA fibers
were stained with rat anti-BrdU antibody (which detects CldU but not IdU,
OBT0030, 1:2,000, AbDSerotec) and mouse anti-BrdU antibody (which de-
tects IdU but not CldU, 7580, 1:1,000, BD Biosciences). Images of DNA fibers
were acquired using a FluoView1000 confocal microscope (Olympus). The
lengths of red- and green-labeled fibers were determined by FluoView3.0 soft-
ware (Olympus).Analysis of Genomic Uracil
Genomic DNA (50 mg) was incubated with 4 units of uracil N-glycosylase (UNG;
New England Biolabs) in 20mMof ammonium bicarbonate for 2 hr at 37Cwith
inclusion of 600 fmol of isotope-labeled uracil (13C4H4O2
15N2, Cambridge
Isotope Laboratories, CNLM-3917). After digestion, reaction mixtures were
added to Amicon Ultra-4 centrifugal filter devices (3,000 molecular weight
[MW] cutoff, Millipore). The filtrates were collected, solid phase-extracted
(210142, Carbograph columns, Grace), vacuum-dried, and then re-dissolved
in water. Analyses were subjected to high-performance/pressure liquid chro-
matography (HPLC)-tandem mass spectrometry (MS/MS) (Bruker EVOQ Elite
Triple Quadrupole LC-MS/MS System). A Waters Atlantis Silica hydrophilic
interaction liquid chromatography (HILIC) column (2.1 3 150 mm, 3-mm parti-
cle size) was used at flow rate of 0.4 ml/min with a constant mobile phase of
1 mM of ammonium acetate and 10%methanol in water under a column tem-
perature of 26C. Themass spectrometer was operated in electrospray ioniza-
tion (ESI)-negative mode. Uracil as well as internal standard isotopic uracil
were detected by mass-to-charge ratio (m/z) 111/42 (for uracil) and m/z
117/44 (for isotopic uracil), respectively.
Ligation-Mediated PCR
Genomic DNA was extracted by a method described previously (Gandhi et al.,
2010). To detect all DNA breaks, ligation-mediated (LM) PCR was used as
described previously (Gandhi et al., 2010). Blunt end double-stranded DNA
breaks were detected using the following modifications. Briefly, genomic
DNA was directly ligated with the asymmetric duplex linkers, followed by
nested PCR to amplify the ligated DNA breaks. The final PCR products were
then resolved by gel electrophoresis and sequenced to verify the breakpoint
location. The linker and PCR primer sequences are described in a paper pub-
lished previously, with the exception of the primer sets for WWOX (Gandhi
et al., 2010). For detection of breaks within WWOX, the biotinylated primers
WWOX4 (50-bb-CCTCTTCCTGGCTCTAGGAGAGAGC-30 ), WWOX20 (50-CATT
GTCCCTGGCCACAAGGACC-30), and WWOX30 (50-GTCCGAGCAGAGTGAA
TGAGCGG-30) were used.
Patient Samples and IHC
A series of 209 consecutive CRC patients from City of Hope National Medical
Center were entered in this study. All participants had CRC with pathological
diagnosis, gave informed consent, and received at least one follow-up. CRC
patients received surgical treatment between 1980 and 2004. The tumor sam-
ple preparation and the detailed criteria for all IHC assessments were as
described previously (Liu et al., 2011, 2013). Two independent investigators re-
viewed and scored the subcellular localization (i.e., cytoplasm versus nucleus),
staining intensity (i.e., integrated optical density), and/or percentage of stained
cells (i.e., total area or percentage of cells positive) for each image. Discrep-
ancies in scores were resolved after joint review by the readers. All patients
were followed up until June 2007, and their demographic distribution is
described in Table 1.
Statistics
Statistical analysis was performed using Student’s t test. Differences were
considered statistically significant when the p value was < 0.05. Error bars
represent the SEM of at least three independent experiments.
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